US2006148001A1PendingUtilityA1
Compositions and methods for treating female fertility
Est. expiryAug 3, 2021(expired)· nominal 20-yr term from priority
Inventors:Alberto Mantovani
A01K 67/0276A01K 2217/075A01K 2227/105A01K 2267/03A61K 38/1709A61K 48/00A61K 49/0004C12N 15/8509C12N 2750/14111C12N 2840/203G01N 33/689G01N 33/74G01N 2333/4756G01N 2800/367
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The PTX3 gene or equivalent PTX3 activity is required for female fertility. Manipulation of PTX3 activity will regulate female fertility. The effects of female sterility may be ameliorated, reproductive ability may be increased or decreased as desired, female fertility may be enhanced, or combinations thereof. The need for therapies that affect female fertility is thereby addressed.
Claims
exact text as granted — not AI-modified1 . A method of screening a pharmaceutical compound to asses the capability of said compound to affect the reproductive ability in a female subject comprising measuring or detecting the ability or effectiveness of said compound to increase or decrease the presence or activity of PTX3 in the extracellular matrix of cumulous oophorus, or measuring or detecting the ability or effectiveness of said compound to increase or decrease the presence or activity of PTX3 expressed from granulosa cells, or measuring or detecting the ability or effectiveness of said compound to bind or inhibit the binding of PTX3 to a target receptor or to function.
Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.